{
  "pathway": "Pharmacy First - Infected Insect Bites (≥1 year)",
  "metadata": {
    "version": "1.0",
    "lastUpdated": "2025-02-15",
    "sources": [
      "https://clinicalpathways.uk/pharmacy/infected-insect-bites/",
      "https://cks.nice.org.uk/topics/insect-bites-stings/",
      "https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN01010-4a.-Infected-insect-bites-flucloxacillin-patient-group-direction-Pharmacy-First.pdf"
    ],
    "niceGuideline": "NICE CKS Insect Bites and Stings"
  },
  "notes": [
    "Exclude pregnant individuals under 16 years and patients without signs of infection—rapid-onset reactions are usually inflammatory/allergic and resolve with self-care.",
    "Document bite/sting history (location, timing, travel history, animal/human exposure), lesion photography if available, systemic symptoms, comorbidities and allergy status before deciding on PGD supply.",
    "Share safety-netting: demarcate erythema, advise urgent review if spreading rapidly, fever, lymphangitis, severe pain, or systemic features occur.",
    "Recommend oral antihistamines, topical corticosteroids and avoidance of scratching to reduce inflammation even when antibiotics are supplied.",
    "Provide wound hygiene advice (wash with soap/water, keep nails short, avoid occlusive dressings) and counsel that mild redness/itching can persist up to 10 days." 
  ],
  "decisionTree": {
    "id": "complication_screen",
    "type": "decision",
    "title": "Consider the risk of deterioration or serious illness",
    "question": "Does the patient meet urgent referral criteria?",
    "details": {
      "urgentCriteria": [
        "Systemically very unwell or NEWS2 trigger (tachycardia, fever, hypotension).",
        "Rapidly spreading cellulitis, lymphangitis or suspicion of sepsis/necrotising infection.",
        "Facial/periorbital involvement, airway compromise, or bites on genitals."
      ],
      "redFlags": [
        "Suspected insect-borne disease (malaria, Lyme disease) requiring medical assessment.",
        "Immunocompromised host (chemotherapy, uncontrolled diabetes, chronic ulcer)."
      ]
    },
    "yes": {
      "id": "urgent_referral",
      "type": "action",
      "title": "Onward referral",
      "actions": [
        "Consider NEWS2 before arranging emergency care.",
        "Refer to GP, urgent care or A&E/999 as clinically indicated.",
        "Do not supply under PGD; provide written safety-netting."
      ],
      "safetyNet": true
    },
    "no": {
      "id": "exposure_screen",
      "type": "decision",
      "title": "Exposure needing medical review",
      "question": "Does the patient meet ANY of the following criteria?",
      "details": {
        "highRiskExposures": [
          "Bite or scratch caused by animal(s).",
          "Bite caused by human(s).",
          "Tick bite in the UK plus erythema migrans or Lyme disease signs.",
          "Bite/sting acquired outside the UK with concern for malaria or other vector-borne disease.",
          "Bite/sting caused by unusual or exotic insect."
        ]
      },
      "yes": {
        "id": "exposure_referral",
        "type": "action",
        "title": "Onward referral",
        "actions": [
          "Refer to GP or appropriate service for further assessment and prophylaxis.",
          "Document exposure details and provide safety-netting advice."
        ],
        "safetyNet": true
      },
      "no": {
        "id": "wait_48h",
        "type": "decision",
        "title": "Timing since bite",
        "question": "Has it been at least 48 hours since the initial bite or sting?",
        "details": {
          "timingNotes": [
            "Most inflammatory reactions improve within 48 hours without antibiotics.",
            "Delay antibiotic consideration until ≥48 hours unless patient becomes systemically unwell."
          ]
        },
        "no": {
          "id": "early_reassurance",
          "type": "action",
          "title": "Too early for infection",
          "actions": [
            "Recommend self-care, oral antihistamines and/or topical steroids.",
            "Advise patient to return if symptoms worsen or persist beyond 48 hours."
          ],
          "safetyNet": true
        },
        "yes": {
          "id": "itch_principal",
          "type": "decision",
          "title": "Symptom assessment",
          "question": "Is itch the principal symptom (no other infection signs)?",
          "details": {
            "itchAdvice": [
              "Normal redness/itching can last up to 10 days.",
              "Encourage avoidance of scratching and continue non-prescription treatments."
            ]
          },
          "yes": {
            "id": "itch_selfcare",
            "type": "action",
            "title": "Likely inflammatory reaction",
            "actions": [
              "Recommend self-care, oral antihistamine and/or topical steroids.",
              "Provide safety-netting and explain infection is unlikely."
            ],
            "safetyNet": true
          },
          "no": {
            "id": "infection_symptoms",
            "type": "decision",
            "title": "Acute infection symptoms",
            "question": "Does the patient have acute onset of ≥3 infection symptoms?",
            "details": {
              "infectionSymptoms": [
                "Redness of skin.",
                "Pain or tenderness at the bite site.",
                "Swelling of the skin.",
                "Skin around the bite feels hot to touch."
              ]
            },
            "no": {
              "id": "monitor_selfcare",
              "type": "action",
              "title": "Monitor and support",
              "actions": [
                "Recommend self-care and OTC antihistamine/topical steroid.",
                "Reassure that itching can persist up to 10 days and infection remains unlikely.",
                "Avoid scratching to reduce inflammation and infection risk."
              ],
              "safetyNet": true
            },
            "yes": {
              "id": "progression_screen",
              "type": "decision",
              "title": "Signs of spreading infection",
              "question": "Does the patient meet ANY of the following criteria?",
              "details": {
                "spreadingSigns": [
                  "Redness/swelling surrounding the bite is spreading.",
                  "Evidence of pustular discharge at the bite/sting site."
                ]
              },
              "no": {
                "id": "demarcate_monitor",
                "type": "action",
                "title": "Localised infection suspected",
                "actions": [
                  "Demarcate erythema and ask patient to monitor.",
                  "Provide self-care advice and review if symptoms worsen or fail to improve after 3 days of OTC treatment."
                ],
                "safetyNet": true
              },
              "yes": {
                "id": "gateway_clinical",
                "type": "decision",
                "title": "Gateway point",
                "question": "Does the patient meet ANY escalation criteria (requires referral)?",
                "details": {
                  "escalationCriteria": [
                    "Patient systemically unwell.",
                    "Comorbidity that may delay resolution (peripheral arterial disease, chronic venous insufficiency, lymphoedema, morbid obesity).",
                    "Severe pain out of proportion to the wound (consider toxin-producing bacteria).",
                    "Significant fluid/pus collection at site (consider incision and drainage)."
                  ]
                },
                "yes": {
                  "id": "escalation_referral",
                  "type": "action",
                  "title": "Referral required",
                  "actions": [
                    "Refer to GP/urgent care for potential oral/IV therapy or procedural management.",
                    "Continue supportive care and document reasons for referral."
                  ],
                  "safetyNet": true
                },
                "no": {
                  "id": "penicillin_allergy",
                  "type": "decision",
                  "title": "Reported penicillin allergy",
                  "question": "Is there a confirmed penicillin allergy?",
                  "yes": {
                    "id": "pregnancy_check",
                    "type": "decision",
                    "title": "Pregnancy consideration",
                    "question": "Is the adult patient pregnant?",
                    "yes": {
                      "id": "erythromycin_treatment",
                      "type": "treatment",
                      "title": "Erythromycin (penicillin allergy + pregnancy)",
                      "drug": "Erythromycin",
                      "durationDays": 5,
                      "dose": {
                        "Adults": "500 mg four times daily (or 1 g twice daily modified-release) for 5 days."
                      },
                      "formulations": [
                        "Tablets/capsules 250 mg, 500 mg",
                        "Oral suspension 125 mg/5 mL, 250 mg/5 mL"
                      ],
                      "route": "Oral (with food).",
                      "legalCategory": "POM (PGD)",
                      "plus": [
                        "Counsel regarding GI effects and importance of completing 5-day course.",
                        "Advise to seek review if jaundice, severe vomiting or rash occurs."
                      ],
                      "followUp": "Return/phone GP if no improvement within 2–3 days or earlier if worsening.",
                      "safetyNet": true,
                      "referralIfWorsen": true
                    },
                    "no": {
                      "id": "clarithromycin_treatment",
                      "type": "treatment",
                      "title": "Clarithromycin (penicillin allergy)",
                      "drug": "Clarithromycin",
                      "durationDays": 5,
                      "dose": {
                        "Children 1–11 years by weight": {
                          "≤8 kg": "7.5 mg/kg twice daily",
                          "8–11 kg": "62.5 mg twice daily",
                          "12–19 kg": "125 mg twice daily",
                          "20–29 kg": "187.5 mg twice daily",
                          "30–40 kg": "250 mg twice daily"
                        },
                        "≥12 years and adults": "500 mg twice daily"
                      },
                      "formulations": [
                        "Tablets 250 mg, 500 mg",
                        "Suspension 125 mg/5 mL, 250 mg/5 mL"
                      ],
                      "route": "Oral (with or without food).",
                      "legalCategory": "POM (PGD)",
                      "plus": [
                        "Check drug interactions (statins, anticoagulants, QT prolongation).",
                        "Encourage hydration and adherence; report taste changes or GI upset if severe."
                      ],
                      "followUp": "Reassess if symptoms worsen or fail to improve after 2–3 days.",
                      "safetyNet": true,
                      "referralIfWorsen": true
                    }
                  },
                  "no": {
                    "id": "fluclox_treatment",
                    "type": "treatment",
                    "title": "Flucloxacillin (first line)",
                    "drug": "Flucloxacillin",
                    "durationDays": 5,
                    "dose": {
                      "Children 1–2 years": "125 mg four times daily",
                      "Children 2–9 years": "250 mg four times daily",
                      "Children 10–17 years and adults": "500 mg four times daily"
                    },
                    "formulations": [
                      "Capsules 250 mg, 500 mg",
                      "Oral solution 125 mg/5 mL or 250 mg/5 mL (standard and sugar-free)"
                    ],
                    "route": "Oral on an empty stomach (1 hour before or 2 hours after food).",
                    "legalCategory": "POM (PGD)",
                    "plus": [
                      "Warn that sugar-free solutions may taste unpleasant; discuss alternatives if adherence at risk.",
                      "Advise monitoring for GI upset or cholestatic jaundice; stop and seek advice if symptoms occur."
                    ],
                    "followUp": "Return if symptoms worsen or do not improve after completion of 5 days.",
                    "safetyNet": true,
                    "referralIfWorsen": true
                  }
                }
              }
            }
          }
        }
      }
    }
  }
}
